The AMA and 61 healthcare organizations are urging Congress to advance four Medicare reforms to stabilize physician payments and protect patient access to care. The post 62 Organizations Call on Congress to Advance 4 Medicare Reforms appeared first on MedCity News.

Blackstone Life Sciences is placing a bet on Pfizer’s berobenatide, a GLP-1 drug designed for monthly dosing. This GLP-1 drug comes from Metsera, which Pfizer acquired last year in a $10 billion deal. The post Pfizer Deal With Blackstone Secures Up to $1.5B to Bankroll GLP-1 Drug Trials appeared first on MedCity News.

Healthcare systems are investing in AI to streamline workflows and save money, but a new study in the New England Journal of Medicine shows that AI-generated care plans might actually cost far more than those ordered by physicians. . The post Is AI Really Saving Hospitals Money? A New Study Raises Questions About the Cost of AI-Driven Care appeared first on MedCity News.

[Sponsored] Join us on December 9 at 1 p.m. ET for an Inovalon-sponsored webinar, where panelists will discuss why hospitals and post-acute care facilities continue to struggle with staffing shortages and turnover. They will also share practical ways to keep employees engaged, reduce burnout, and build more stable care teams. The post Sustaining Effective Care Teams During Staff Shortages  appeared first on MedCity News.

A large health system absorbs an appeal as routine. For a small agency with a few office staff, every hour chasing a physician signature or a face-to-face note is an hour not spent on patients. The post When the Enrollment Freeze Ends, Claim Review Takes Over — Small Providers Need Clear Rules appeared first on MedCity News.

Users are, rightfully, upset that the devices they bought are not delivering the results they were promised. But is that indignation pointed at the right flaw? The post Beyond Metrics: How to Repair Our Relationship With Wearables appeared first on MedCity News.

Merck KGaA drug Pimjetmi is now FDA approved for treating tenosynovial giant cell tumor. This drug complements other rare tumor assets the Germany-based drugmaker has acquired in a series of business deals. The post Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy appeared first on MedCity News.

Maven Clinic is making its virtual care services accessible through more than 475 health plans nationwide. The post Maven Clinic’s Virtual Care Clinic Goes In Network with 475 Plans appeared first on MedCity News.

Democrats’ huge wins last week might mean big changes coming to healthcare across the country, especially in states which flipped blue. How might the shift in power affect affordability, access, and coverage? The post Democrats’ Midterm Wins Could Reshape Healthcare Access for Underserved Americans appeared first on MedCity News.

[Sponsored] In an interview, Wayne Luan, senior director, life sciences and provider solutions with Turquoise Health, told MedCity News Editor-in-Chief Arundhati Parmar that the company’s platform provides pricing data for medical services, medical devices, and pharmaceutical drugs. The post Can an Infrastructure for Price Transparency Improve Healthcare Competition and Quality? appeared first on MedCity News.

We spend more than a decade training physicians and teach them almost nothing about leading people. So, what do we do? We take the best clinician in the group, hand them the title, and assume that leadership comes with it. The post Follow the Leader: How to Build and Retain Great Clinical Teams appeared first on MedCity News.

Oura will be integrating Counsel Health’s clinical AI and virtual care into its app, but will payers and employers cover the Oura ring as a benefit? And will consumers sign on to pay a much more expensive monthly subscription for AI-enabled medical insights and access to licensed physicians? The post Oura Buys Counsel for $625M, But Will Payers and Consumers Get on Board? appeared first on MedCity News.

Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class of cardiovascular medicines. Approval of the once-daily pill covers secondary stroke prevention in adults. The post FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke appeared first on MedCity News.

Healthcare has plenty of tedious administrative work which could benefit from AI’s efficiency – but what if simply speeding up an already broken system isn’t the answer? Healthcare leaders push for a re-built, AI-native system in Anterior’s recent Beyond Faster Horses campaign. The post New Campaign Wants AI Applications To Look Beyond Speed appeared first on MedCity News.

The industry’s next major competitor may never build another national laboratory network or employ thousands of phlebotomists. It may simply own the device that notices something first. The post The Laboratory Industry’s Next Competitor May Be the Company on Your Patient’s Wrist appeared first on MedCity News.